Concepts (165)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diet, High-Fat | 2 | 2012 | 137 | 0.720 |
Why?
|
| Insulin-Like Growth Factor I | 3 | 2011 | 301 | 0.710 |
Why?
|
| Pyrimidines | 4 | 2015 | 125 | 0.680 |
Why?
|
| NF-E2-Related Factor 2 | 5 | 2012 | 122 | 0.680 |
Why?
|
| Aging | 5 | 2012 | 968 | 0.620 |
Why?
|
| Oxidative Stress | 7 | 2025 | 668 | 0.620 |
Why?
|
| Neoplasm Micrometastasis | 2 | 2015 | 6 | 0.570 |
Why?
|
| Angiogenesis Inhibitors | 3 | 2013 | 109 | 0.570 |
Why?
|
| Antineoplastic Agents | 5 | 2015 | 679 | 0.570 |
Why?
|
| Aorta | 4 | 2011 | 124 | 0.550 |
Why?
|
| Obesity | 3 | 2017 | 669 | 0.540 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 2014 | 50 | 0.500 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2014 | 156 | 0.470 |
Why?
|
| Neoplasm Metastasis | 2 | 2015 | 162 | 0.450 |
Why?
|
| Hyperoxia | 2 | 2025 | 79 | 0.430 |
Why?
|
| Disease Models, Animal | 4 | 2013 | 1461 | 0.410 |
Why?
|
| Breast Neoplasms | 3 | 2015 | 459 | 0.400 |
Why?
|
| Pyrroles | 1 | 2013 | 36 | 0.400 |
Why?
|
| Drug Design | 1 | 2013 | 63 | 0.390 |
Why?
|
| Vascular Diseases | 1 | 2012 | 68 | 0.380 |
Why?
|
| Adipose Tissue | 1 | 2012 | 183 | 0.360 |
Why?
|
| Growth Hormone | 1 | 2011 | 103 | 0.360 |
Why?
|
| Lung Neoplasms | 1 | 2014 | 356 | 0.330 |
Why?
|
| Liver | 2 | 2011 | 440 | 0.320 |
Why?
|
| Animals | 16 | 2025 | 10423 | 0.310 |
Why?
|
| Mice | 10 | 2025 | 4654 | 0.300 |
Why?
|
| Inflammation | 1 | 2012 | 636 | 0.290 |
Why?
|
| Cell Line, Tumor | 7 | 2015 | 1319 | 0.260 |
Why?
|
| Selenium | 1 | 2025 | 17 | 0.230 |
Why?
|
| Apoptosis | 5 | 2015 | 775 | 0.220 |
Why?
|
| Neurons | 2 | 2017 | 283 | 0.200 |
Why?
|
| Epithelial Cells | 1 | 2024 | 248 | 0.200 |
Why?
|
| Hyperglycemia | 3 | 2011 | 78 | 0.190 |
Why?
|
| Lung | 1 | 2025 | 379 | 0.190 |
Why?
|
| Mice, Inbred BALB C | 4 | 2015 | 276 | 0.180 |
Why?
|
| Carotid Arteries | 2 | 2011 | 54 | 0.180 |
Why?
|
| Coronary Vessels | 2 | 2012 | 152 | 0.170 |
Why?
|
| Hydrogen Peroxide | 4 | 2011 | 144 | 0.150 |
Why?
|
| Mice, Inbred C57BL | 3 | 2012 | 1576 | 0.150 |
Why?
|
| Mice, Nude | 3 | 2015 | 331 | 0.150 |
Why?
|
| Hypothalamus | 1 | 2017 | 29 | 0.140 |
Why?
|
| Pro-Opiomelanocortin | 1 | 2017 | 14 | 0.140 |
Why?
|
| Endothelial Cells | 3 | 2025 | 352 | 0.140 |
Why?
|
| Tissue Culture Techniques | 3 | 2011 | 31 | 0.140 |
Why?
|
| Glutamate-Cysteine Ligase | 3 | 2011 | 25 | 0.140 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 3 | 2011 | 40 | 0.140 |
Why?
|
| Estradiol | 1 | 2017 | 175 | 0.130 |
Why?
|
| Feeding Behavior | 1 | 2017 | 102 | 0.130 |
Why?
|
| Structure-Activity Relationship | 2 | 2014 | 208 | 0.120 |
Why?
|
| Melanoma, Experimental | 2 | 2013 | 31 | 0.120 |
Why?
|
| Female | 7 | 2025 | 15156 | 0.120 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2011 | 58 | 0.120 |
Why?
|
| Necrosis | 1 | 2015 | 85 | 0.120 |
Why?
|
| Heme Oxygenase-1 | 2 | 2011 | 36 | 0.110 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2015 | 36 | 0.110 |
Why?
|
| Rats | 3 | 2015 | 1576 | 0.110 |
Why?
|
| Aniline Compounds | 1 | 2014 | 23 | 0.110 |
Why?
|
| Indoles | 1 | 2015 | 99 | 0.110 |
Why?
|
| Drug Discovery | 1 | 2014 | 34 | 0.110 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2014 | 48 | 0.110 |
Why?
|
| Neoplasms, Experimental | 1 | 2014 | 58 | 0.110 |
Why?
|
| Doxorubicin | 1 | 2014 | 77 | 0.110 |
Why?
|
| Microtubules | 1 | 2014 | 90 | 0.110 |
Why?
|
| NF-kappa B | 2 | 2011 | 191 | 0.110 |
Why?
|
| Water | 1 | 2014 | 135 | 0.100 |
Why?
|
| Male | 7 | 2015 | 13491 | 0.100 |
Why?
|
| Microwaves | 1 | 2013 | 10 | 0.100 |
Why?
|
| Mice, Obese | 1 | 2012 | 21 | 0.100 |
Why?
|
| Indenes | 1 | 2012 | 2 | 0.100 |
Why?
|
| Oligopeptides | 1 | 2013 | 97 | 0.100 |
Why?
|
| Disease Progression | 1 | 2014 | 473 | 0.100 |
Why?
|
| Rats, Inbred Lew | 1 | 2011 | 34 | 0.090 |
Why?
|
| Dwarfism | 1 | 2011 | 27 | 0.090 |
Why?
|
| Glucose Tolerance Test | 1 | 2011 | 60 | 0.090 |
Why?
|
| Mitochondria | 1 | 2015 | 369 | 0.090 |
Why?
|
| Lipoproteins, LDL | 1 | 2011 | 36 | 0.090 |
Why?
|
| Oxidation-Reduction | 1 | 2012 | 365 | 0.090 |
Why?
|
| Cell Survival | 1 | 2013 | 409 | 0.090 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 134 | 0.090 |
Why?
|
| Membrane Proteins | 2 | 2011 | 484 | 0.090 |
Why?
|
| Cellular Senescence | 1 | 2012 | 125 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2011 | 247 | 0.090 |
Why?
|
| Cell Proliferation | 4 | 2015 | 806 | 0.080 |
Why?
|
| Blood Glucose | 1 | 2011 | 309 | 0.080 |
Why?
|
| Insulin | 1 | 2011 | 315 | 0.080 |
Why?
|
| Adaptation, Physiological | 1 | 2011 | 169 | 0.080 |
Why?
|
| Hippocampus | 1 | 2011 | 188 | 0.080 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2015 | 269 | 0.080 |
Why?
|
| Cytokines | 1 | 2011 | 447 | 0.080 |
Why?
|
| Depression | 1 | 2011 | 216 | 0.080 |
Why?
|
| Antioxidants | 1 | 2011 | 223 | 0.080 |
Why?
|
| Humans | 7 | 2024 | 28097 | 0.070 |
Why?
|
| Mice, Inbred C3H | 1 | 2025 | 74 | 0.060 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2025 | 47 | 0.060 |
Why?
|
| Animals, Newborn | 1 | 2025 | 180 | 0.060 |
Why?
|
| Trachea | 1 | 2024 | 26 | 0.060 |
Why?
|
| Behavior, Animal | 2 | 2017 | 108 | 0.060 |
Why?
|
| Respiratory Mucosa | 1 | 2024 | 51 | 0.050 |
Why?
|
| Oxygen | 1 | 2025 | 233 | 0.050 |
Why?
|
| Cell Culture Techniques | 1 | 2024 | 116 | 0.050 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2014 | 103 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2017 | 507 | 0.050 |
Why?
|
| Chick Embryo | 2 | 2013 | 27 | 0.050 |
Why?
|
| Homeostasis | 2 | 2015 | 118 | 0.050 |
Why?
|
| Cell Movement | 2 | 2015 | 373 | 0.050 |
Why?
|
| Neovascularization, Physiologic | 2 | 2013 | 124 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2014 | 607 | 0.050 |
Why?
|
| Infant, Newborn | 1 | 2024 | 885 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2011 | 985 | 0.040 |
Why?
|
| Arcuate Nucleus of Hypothalamus | 1 | 2017 | 5 | 0.040 |
Why?
|
| Eating | 1 | 2017 | 70 | 0.030 |
Why?
|
| Leptin | 1 | 2017 | 67 | 0.030 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2015 | 34 | 0.030 |
Why?
|
| Maximum Tolerated Dose | 1 | 2015 | 31 | 0.030 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2015 | 25 | 0.030 |
Why?
|
| Cell Membrane Permeability | 1 | 2015 | 44 | 0.030 |
Why?
|
| Superoxides | 1 | 2015 | 62 | 0.030 |
Why?
|
| Solubility | 1 | 2014 | 73 | 0.030 |
Why?
|
| Calcium | 1 | 2015 | 235 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2014 | 208 | 0.030 |
Why?
|
| Solid-Phase Synthesis Techniques | 1 | 2013 | 4 | 0.030 |
Why?
|
| Chorioallantoic Membrane | 1 | 2013 | 7 | 0.030 |
Why?
|
| CD13 Antigens | 1 | 2013 | 26 | 0.030 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2012 | 21 | 0.020 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2012 | 28 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2012 | 138 | 0.020 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 2011 | 12 | 0.020 |
Why?
|
| Vasculitis | 1 | 2011 | 13 | 0.020 |
Why?
|
| Hindlimb Suspension | 1 | 2011 | 8 | 0.020 |
Why?
|
| Exploratory Behavior | 1 | 2011 | 12 | 0.020 |
Why?
|
| Macaca mulatta | 1 | 2011 | 50 | 0.020 |
Why?
|
| Inhibitor of Differentiation Proteins | 1 | 2011 | 11 | 0.020 |
Why?
|
| Rats, Inbred BN | 1 | 2011 | 70 | 0.020 |
Why?
|
| Oxidants | 1 | 2011 | 31 | 0.020 |
Why?
|
| Microcirculation | 1 | 2012 | 112 | 0.020 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2011 | 38 | 0.020 |
Why?
|
| Swimming | 1 | 2011 | 32 | 0.020 |
Why?
|
| Mice, Inbred ICR | 1 | 2011 | 26 | 0.020 |
Why?
|
| Kelch-Like ECH-Associated Protein 1 | 1 | 2011 | 15 | 0.020 |
Why?
|
| Maze Learning | 1 | 2011 | 78 | 0.020 |
Why?
|
| Rats, Inbred F344 | 1 | 2011 | 174 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2011 | 101 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2011 | 77 | 0.020 |
Why?
|
| Acetylcysteine | 1 | 2011 | 24 | 0.020 |
Why?
|
| Cytoskeletal Proteins | 1 | 2011 | 42 | 0.020 |
Why?
|
| Catalase | 1 | 2011 | 49 | 0.020 |
Why?
|
| Time Factors | 1 | 2015 | 1592 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2011 | 94 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2011 | 116 | 0.020 |
Why?
|
| Linear Models | 1 | 2011 | 202 | 0.020 |
Why?
|
| Dietary Fats | 1 | 2011 | 59 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 257 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 391 | 0.020 |
Why?
|
| Polyethylene Glycols | 1 | 2011 | 101 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2011 | 193 | 0.020 |
Why?
|
| Glucose | 1 | 2011 | 204 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2011 | 163 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2011 | 403 | 0.020 |
Why?
|
| Gene Expression | 1 | 2011 | 417 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2011 | 285 | 0.020 |
Why?
|
| Age Factors | 1 | 2011 | 734 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2011 | 659 | 0.020 |
Why?
|
| Proteins | 1 | 2011 | 252 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2011 | 325 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2011 | 632 | 0.020 |
Why?
|